Literature DB >> 1601325

Role of reactive oxygen species in intestinal diseases.

A van der Vliet1, A Bast.   

Abstract

It is well known that reactive oxygen metabolites are generated during several pathologies, and that they are able to disturb many cellular processes and eventually lead to cellular injury. After intestinal ischemia, reactive oxygen species are produced when the ischemic tissue is reperfused. The enzyme xanthine oxidase is thought to play a key role in this process. As a result of this oxygen radical production, the permeability of the endothelium and the mucosa increases, allowing infiltration of inflammatory leukocytes into the ischemic area. Moreover, reactive oxygen species are also indirectly involved in leukocyte activation. In turn, these inflammatory cells respond with the production of oxygen radicals, which play an important role in the development of tissue injury. Thus, intestinal ischemia and reperfusion evokes an inflammatory response. Also during chronic intestinal inflammatory diseases, reactive oxygen metabolites are proposed to play an important role in the pathology. Scavenging of reactive oxygen species will thus be beneficial in these disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601325     DOI: 10.1016/0891-5849(92)90103-n

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  26 in total

1.  Mechanism of gastroprotection by bismuth subsalicylate against chemically induced oxidative stress in cultured human gastric mucosal cells.

Authors:  D Bagchi; T R McGinn; X Ye; J Balmoori; M Bagchi; S J Stohs; C A Kuszynski; O R Carryl; S Mitra
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.

Authors:  C Loguercio; G D'Argenio; M Delle Cave; V Cosenza; N Della Valle; G Mazzacca; C del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

3.  Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease.

Authors:  B Sido; V Hack; A Hochlehnert; H Lipps; C Herfarth; W Dröge
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

4.  Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis.

Authors:  S Blau; R Kohen; P Bass; A Rubinstein
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

5.  Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon.

Authors:  S Blau; A Rubinstein; P Bass; C Singaram; R Kohen
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

6.  Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon.

Authors:  Tova Rainis; Irit Maor; Amos Lanir; Sergay Shnizer; Alexandra Lavy
Journal:  Dig Dis Sci       Date:  2006-12-29       Impact factor: 3.199

7.  Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage.

Authors:  Eran Israeli; Eduard Berenshtein; Dov Wengrower; Larisa Aptekar; Ron Kohen; Gershom Zajicek; Eran Goldin
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 8.  Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.

Authors:  Halis Suleyman; Abdulmecit Albayrak; Mehmet Bilici; Elif Cadirci; Zekai Halici
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

9.  Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns.

Authors:  S Uguralp; C Irsi; T Aksoy; A Bay Karabulut; H Kirimlioglu; B Mizrak
Journal:  Pediatr Surg Int       Date:  2008-02-19       Impact factor: 1.827

Review 10.  A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase.

Authors:  A Kooij
Journal:  Histochem J       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.